Table 9.

Incremental Utility of Biomarkers Over Standard Risk Factors Using ASE Criteria for Defining LVH

	Composite	LVH_ASE
Standard risk factors (1)	0.76 (0.734 to 0.780)	0.77 (0.743 to 0.789)
Standard risk factors+BNP (2)	0.76 (0.739 to 0.785)	0.77 (0.748 to 0.794)
Standard risk factors+biomarkers* (3)	0.77 (0.743 to 0.788)	0.77 (0.751 to 0.796)
P for difference (1 vs 3)	0.03	0.03
P for difference (2 vs 3)	0.19	0.26

Values are C statistics (95% CI) and P‐values. ASE indicates American Society of Echocardiography; BNP, B‐type natriuretic peptide; LVH, left ventricular hypertrophy.

^*Model includes standard risk factors, BNP and the biomarker that was significantly associated with each outcome.